tenk.fyi

IMMUCELL CORP /DE/

ICCCNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$26.5M

51.6% YoY

Net Income

-$2.2M

62.7% YoY

EPS

$-0.26

65.3% YoY

Cash

$3.8M

284.0% YoY

FY 2024 · As of 2024-12-31